Cas 763131-65-3,N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide

763131-65-3

Post Buying Request

Basic information

Product Name: N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide
Synonyms: N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide
CAS NO:763131-65-3
Molecular Formula:
Molecular Weight: 366.423
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide(CAS DataBase Reference)
NIST Chemistry Reference: N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide(763131-65-3)
EPA Substance Registry System: N-[2-(dimethylamino)ethyl]-2-{4-[(1-oxido-1,2,4-benzotriazin-3-yl)amino]phenyl}acetamide(763131-65-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 763131-65-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

763131-65-3 Suppliers

Recommended suppliers

763131-65-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 763131-65-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,3,1,3 and 1 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 763131-65:
(8*7)+(7*6)+(6*3)+(5*1)+(4*3)+(3*1)+(2*6)+(1*5)=153
153 % 10 = 3
So 763131-65-3 is a valid CAS Registry Number.

763131-65-3Upstream product

763131-65-3Downstream Products

763131-65-3Relevant academic research and scientific papers

Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments

-

Page/Page column 28; 58, (2010/02/08)

The present invention relates to a synergetistic composition comprising one or more benzoazine-mono-N-oxides, and one or more benzoazine 1,4 dioxides for use in cancer therapy. The invention also provides a range of novel 1,2,4 benzoazine-mono-N-oxides and related analogues. These can be used as potentiators of the cytotoxicity of existing anticancer drugs and therapies for cancer treatment.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 763131-65-3